iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd Option Chain

Add as a Preferred Source on Google
2,202.7
(1.76%)
Jan 2, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,800₹3.8 0%5,1750%
2250%₹232.5 0%1,900₹2.45 -1.99%1,350100%
--1,950₹4.5 0%1,3500%
4,9500%₹205 4.19%2,000₹3.4 -38.18%11,2508.69%
--2,040₹9 0%4500%
--2,060₹7.35 -44.52%8,7752.63%
2250%₹135.5 0%2,080₹18 0%2250%
675-25%₹110 -15.38%2,100₹14.45 -35.49%60,300-4.96%
12,150-12.90%₹87 33.23%2,150₹24.2 -40.02%42,525-8.69%
6750%₹62.3 0%2,160₹36.7 0.13%1,12525%
8,775-35%₹65.25 29.46%2,180--
1,09,350-15.18%₹56.5 36.14%2,200₹45 -32.53%1,48,50074.14%
68,625535.41%₹45.55 30.32%2,220--
5,175-17.85%₹36.6 30.48%2,240--
28,800-13.51%₹33.65 35.41%2,250₹83.65 0%18,9000%
2,0250%₹23.1 0%2,260--
9000%₹25 44.92%2,280--
59,4000.38%₹19 36.69%2,300₹111 -9.93%8,325-5.12%
17,1007.04%₹10.25 39.45%2,350₹166 0%6750%
4500%₹11.6 -10.42%2,360--
36,00040.35%₹5.15 28.75%2,400₹213.2 0%6,3000%
4,05063.63%₹2.95 -1.66%2,450₹267.55 0%3,1500%
5,17543.75%₹0.65 -55.17%2,500₹300 0%4,5000%
--2,600₹400 0%1,3500%
2250%₹0.45 0%2,700₹515 0%2250%

Mankind Pharma: Related NEWS

Mankind Pharma Q1 Updates: Net profit down ~18%

The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.

1 Aug 2025|01:41 PM
Read More
Top Stocks for Today - 01st August 2025

Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.

1 Aug 2025|08:58 AM
Read More
Mankind Pharma posts mixed performance in Q4; stock slips ~4%

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

22 May 2025|12:15 PM
Read More
Top Stocks for Today - 22nd May 2025

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

22 May 2025|06:38 AM
Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand

The cumulative demand, including interest charges, is ₹183.11 crore.

30 Mar 2025|04:34 PM
Read More
Mankind Pharma Merges Three Subsidiaries

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

30 Mar 2025|01:33 PM
Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

28 Feb 2025|11:13 PM
Read More
Top Stocks for Today - 24th January 2025

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

24 Jan 2025|07:50 AM
Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

23 Jan 2025|11:57 PM
Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

8 Jan 2025|04:01 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.